Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lyell Immunopharma (LYEL) Asset Writedowns and Impairment (2021 - 2025)

Lyell Immunopharma (LYEL) has disclosed Asset Writedowns and Impairment for 4 consecutive years, with $1.4 million as the latest value for Q2 2025.

  • Quarterly Asset Writedowns and Impairment changed N/A to $1.4 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $52.7 million through Dec 2025, up 13.82% year-over-year, with the annual reading at $1.4 million for FY2025, 97.19% down from the prior year.
  • Asset Writedowns and Impairment hit $1.4 million in Q2 2025 for Lyell Immunopharma, down from $51.3 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $51.3 million in Q4 2024 to a low of -$5.0 million in Q4 2022.
  • Historically, Asset Writedowns and Impairment has averaged $17.8 million across 4 years, with a median of $5.0 million in 2022.
  • Biggest YoY gain for Asset Writedowns and Impairment was 113.74% in 2022; the steepest drop was 113.74% in 2022.
  • Year by year, Asset Writedowns and Impairment stood at $36.4 million in 2021, then crashed by 113.74% to -$5.0 million in 2022, then skyrocketed by 1126.0% to $51.3 million in 2024, then plummeted by 97.27% to $1.4 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for LYEL at $1.4 million in Q2 2025, $51.3 million in Q4 2024, and -$5.0 million in Q4 2022.